New Recall Hits Popular Brand of Blood Pressure Medication, 'Cancer Risk' Associated with Drug

April 29, 2019Apr 29, 2019

A new recall has just been announced for a popular blood pressure medication. Losartan has announced they are recalling new lots of their drug for fear it may have cancer-related links.

"Teva Pharmaceuticals USA, Inc. has initiated a voluntary recall in the United States of 35 lots of bulk Losartan Potassium USP Tablets. This recall is due to the detection of a cancer-causing impurity – N-Nitroso-N-methyl-4-aminobutyric acid (NMBA)," wrote Fox.

According to reports, the drug was sold exclusively to a California based medical supply company. The bulk product was sold under their own label and distributed in bottles of 30, 90, and 1000 tablets.

The products in question can be seen below:

-Losartan Potassium tablets, USP 25 mg, are light-green, film-coated, teardrop-shaped biconvex tablet with “LK 25” on one side and “>” on the other side

-Losartan Potassium tablets, USP 100 mg, are dark green, film-coated, oval-shaped biconvex tablets with “LK100” on one side and “>” on the other side

At this time, the recall is a preemptive action to stop customers from having adverse effects. There have not been any cancer related incidents at this time.

The pills were sold exclusively to Golden State Medical Supply of Camarillo, California, according to Fox News. Golden State Medical Supply packaged them and branded them under their own marketing.

Please be sure and check your medication to see if yours is included in this recall! In other recent news, fans are gushing after Joanna Gaines posts sweetest photo of baby Crew with dad Chip.

Next: Fans Melt After Joanna Gaines Posts Most Adorable Photos of Baby Crew and Dad ChipApr 29, 2019